Philippine Health Research Registry
Display Options
Results List
Results 1 - 8 of 8 research(es) under Allergan Healthcare Philippines, Inc.

Show: All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#
Study
         
Project Status:
Ongoing
Project Description:
Bimatoprost Preservative-Free (PF) Intracameral (IC) Drug Delivery System (DDS) (sustained-release biodegradable implants containing preservative-free AGN-192024 [bimatoprost])
Project Status:
Terminated
Project Description:
This study is being conducted to establish the potential role of bimatoprost 0.03% PF in the management of paediatric glaucoma. The intent of this paediatric investigation is to evaluate the safety and efficacy of bimatoprost in the management of glaucoma in paediatric patients in whom surgical intervention is not indicated or anticipated for IOP l... [read more]
Project Status:
Pending
Project Description:
A multicenter, randomized, comparative study 12 months with the use of 700 μg DEX PS DDS
Project Status:
Ongoing
Project Description:
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 12-week study evaluating 2 doses of BOTOX, 4 and 8 U/kg, and placebo with standardized Physical Therapy (PT) for the treatment of spasticity involving the ankle plantar flexors in monoplegic and hemiplegic children.
Project Status:
Ongoing
Project Description:
Structure: Multicenter, open-label study Duration: Approximately 60 weeks Study Treatment Groups: BOTOX Controls: None Dosage/Dose Regimen (BOTOX doses are expressed per body weight): There will be up to 5 treatments in the study. For the first treatment cycle, de novo patients (who did not participate in Allergan Study 191622-101) are to receive a... [read more]
Project Status:
Ongoing
Project Description:
Structure: Multicenter, randomized, double-blind, placebo-controlled, parallel-group Duration: 16 weeks (up to 4 weeks of screening and 12 weeks of posttreatment follow-up) Study Treatment Groups (BOTOX doses are expressed as units per total body weight): 4 U/kg BOTOX + PT 8 U/kg BOTOX + PT Placebo + PT Control: Placebo Dosage/Dose Regimen: There w... [read more]
Project Status:
Pending
Project Description:
Structure: Multicenter, open–label study Duration: Approximately 60 weeks Study Treatment Groups: BOTOX Controls: None Dosage/Dose Regimen (BOTOX doses are expressed per body weight): There will be up to 5 treatments in the study. For the first treatment cycle, de novo patients (who did not participate in Allergan Study 191622-111) are to receive... [read more]
Project Status:
Ongoing
Project Description:
a randomized, patient and efficacy evaluator-masked, parallel-group comparison to evaluate the safety and IOP-lowering effects of repeated administrations of 10 μg or 15 μg Bimatoprost SR in patients with OAG or OHT and open iridocorneal angles inferiorly in the study eye by clinical gonioscopy.